The Searle Company Limited (SEARL): Result Preview – By Taurus Research

<ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">4QFY25: &ndash; EPS: PKR 1.10, PAT: PKR 562Mn, up 1.3x over the SPLY.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">During 4QFY25, revenue is expected to arrive at PKR 6.8Bn as compared to PKR 7.1Bn, down 5%YoY/3%QoQ, mainly due to lower sales during the quarter on the back of seasonality. Gross margins are expected to increase 2pptsYoY arriving ~50% as compared to ~48% driven by higher prices of medicines. Whereas, on a quarterly basis margin to decline 1ppts driven by lower volumetric sales. Finance costs to decline 65%YoY/9%QoQ primarily due to reduced interest rates.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">PAT to clock-in at PKR 562Mn, up 2.5...